纤维化相关的非编码RNAs在 keloids:双重的角色在致病和治疗:一个审查
Yunchao Zhang1, Xi Zhang2, Yiming Qin1
1Department of Dermatology and Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, PR China.
International journal of biological macromolecules
|September 18, 2025
概括
非编码RNAs (ncRNAs) 通过影响纤维细胞功能,在 keloid 纤维化中表现出双重调节作用. 这些ncRNAs,包括外体衍生的ncRNAs (Exos-ncRNAs),提供了作为生物标志物和治疗标的潜力,以改善 keloid 治疗.
科学领域:
- 生物医学科学 生物医学科学
- 分子生物学分子生物学
- 皮肤病学 皮肤病学
背景情况:
- 质体是由纤维细胞过度增殖和失调的细胞外基质 (ECM) 沉积引起的,导致患者严重的痛苦.
- 目前的化体治疗具有很高的复发率,突出显示了对新治疗策略的需求.
- 非编码RNAs (ncRNAs) 越来越多地被认可为它们在纤维性疾病 (如 keloids) 中的调节作用.
研究的目的:
- 审查了解ncRNAs在 keloid 纤维化中的双重调节作用的最新进展.
- 探索ncRNAs影响纤维细胞功能和微环境重塑的机制.
- 调查外基因组衍生的ncRNAs (Exos-ncRNAs) 的潜力和cRNAs在 keloids 中的临床意义.
主要方法:
- 在过去五年中发表的关于ncrRNAs在 keloid 纤维化中的研究的综合文献综述.
- 对ncRNA调节纤维细胞行为的分子机制的分析.
- 对外体衍生的ncRNAs的评估和ncRNAs作为生物标志物和治疗点的临床应用.
主要成果:
- ncRNAs在 keloid 纤维化中表现出双重调节功能,影响纤维细胞活动和组织重塑.
- 外的ncRNAs 在细胞间通信中发挥作用,调节纤维细胞功能.
- ncRNAs显示出作为 keloid 诊断的生物标志物和作为新型治疗的目标的潜力,与现有药物相关联.
结论:
- ncRNAs是 keloid 纤维化的关键调节者,为治疗干预提供了有前途的途径.
- 了解ncRNAs和Exos-ncRNAs复杂的作用可以导致更有效的 keloid 管理策略.
- 对ncRNA的进一步研究为开发向疗法和改善 keloid 患者的临床结果提供了显著的潜力.
相关概念视频
Introduction to Fibroblasts
3.8K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.8K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
lncRNA - Long Non-coding RNAs
9.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Formation of Muscle Fibers from Myoblasts
5.8K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
5.8K
Clinical Applications of Epidermal Stem Cells
3.3K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.3K


